About Us
We are a French biotech company located in north of Montpellier and sert up on the biopole Euromedecine in Grabels.
Hosted in the Mabqi premises, BindingSolution is committed to turn your expectations into reality.
BindingSolution provides customers with comprehensive panel of BLI analytical service. We are fully committed to build a strong relationship of trust based on open exchanges, discussion and transparency.
Once we have been informed of your request, we will schedule a meeting to discuss your project so as to fully understand and address your needs, objectives and expectations. A confidentiality agreement can be established at this stage. Each project is different and requires a rigorous and mutual understanding to succeed.
In addition to offer robust BLI analytical service, BindingSolution delivers intermediate and final result reports and guaranties to keep you up to date on a daily basis with your latest results.
BindingSolution’s expertise can help you to streamline and empower your drug discovery and development processes.
Stephane Bonetto has founded BindingSolution in 2024. He worked for nearly 20 years for CRO (Isogenica, UK), emerging biotech (F-Star, Avacta, UK) and large pharmaceutical company (Astrazeneca, Agenus, UK) in discovery departments aiming to identify and optimize new biologics medicine for needs across multiple therapeutic areas including oncology, inflammation, neuroscience, diabetes and metabolism disorders. He gained a strong expertise in the completion of early drug discovery projects but also as a leadership in the co-ordination of internal researches / partnerships and commercial services. Recently he was in charge of R&D department at Mabqi to implement and oversee the IgG production platform and BLI measurement platform. He graduated of two Master 2 degrees in Science, one in Cellular biology and another one in Molecular pharmacology, and hold a PhD in immunology in 2005 in the pigmentation disorders field (co-funded by Ipsogen and Galderma R&D, Fr). Today, he takes on the directorship of scientific and strategic decisions at BindingSolution.
